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1. Introduction 
The biosynthesis of a tRNA molecule in prokary- 
otes starts with the transcription of an RNA precursor 
which is converted to tRNA via a multistep process 
involving nucleolytic cleavages, which progressively 
reduce its length, and the modification of several 
nucleosides along the sequence [l] . 
Since the intracellular concentration of the 
maturation intermediates is generally very low, the 
study of tRNA biosynthesis has been greatly facilitatea 
by the isolation of mutants altered in some specific 
steps of the biosynthetic pathway, with consequent 
accumulation of tRNA precursors [2-61. 
In a previous study [3,7] it has been reported that 
hisT mutants of Salmonella typhimurium lack an 
enzyme responsible for the biosynthesis of pseudo- 
uridine in the anticodon region of several tRNA 
species. tRNA Extracted from hisT mutants has been 
used as substrate for in vitro biosynthesis of pseudo- 
uridine and an assay has been set up, which is based 
on the release of tritium from [ 5-3H] uridine-labeled 
hisT tRNA, upon conversion of uridine into pseudo- 
uridine [ 71. 
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On the basis of this study [7] it has been possible 
to postulate the existence of two pseudouridylate 
synthetases: 
(i) Pseudouridylate synthetase I, coded by the 
hisT gene and responsible for the biosynthesis of 
pseudouridine in the anticodon region of several 
tRNA species 
(ii) Pseudouridylate synthetase II, responsible for 
the biosynthesis of pseudouridine in the T$CG loop 
of every tRNA molecule. 
Since the pseudouridine of the anticodon region 
can be synthesized in vitro as the last step of tRNA 
maturation, the question is open as to at what step it 
is actually synthesized in vivo. Guthrie et al. [8] and 
Sakano et al. [9] have found that the pseudouridine 
of the anticodon region and of the T$CG-loop are 
both present in the T4 coded tRNA dimeric precursors. 
A different result was obtained by Shaefer et al. [lo] 
who found that in the tRNATyr precursor accumulat- 
ing in Escherichia coli cells infected by $80~~~3’ A25 
phage mutant strain only the pseudouridine of the 
TJ/CGloop (J/M) was present, whereas the pseudo- 
uridine of the anticodon region ($40) was not present 
and could be synthesized in vitro only after cleavage 
of tRNATYr precursor by RNAase P. 
In this paper we report a study on the in vitro 
biosynthesis of pseudouridine using as substrate the 
tRNATyr precursor, transcribed in vitro from 
@~OPSU~+‘- phage DNA, carrying both suppressor and 
wild-type tRNATYr genes [ 111. We have found that 
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this molecule is substrate for both pseudouridylate 
synthetases and that the pseudouridine of the anti- 
codon region can be synthesized at the level of 
uncleaved tRNATYr precursor transcribed in vitro. 
2. Materials and methods 
2.1. Chemicals 
Tl Ribonuclease was purchased from Sigma 
Chemical Co. Ltd., and all other chemicals used were 
of reagent grade. 
2.2. Bacterial and bacteriophage strains 
Isogenic hisT (TA253) and wild-type (TA265) 
S. typhimurium LT:2 have been described [7]. 
Bacteriophages $80 and q%Opsu3+‘- have also been 
described [11,12]. 
2.3. Preparation of S30 cell-extract 
Preparation of S30 cell-extract from TA265 and 
TA253 strains was performed as described in the 
procedure for partial purification of pseudouridylate 
synthetase I (see later). 
2.4. Partial putification of pseudouridylate synthetase I 
Salmonella typhimurium TA265 strain was grown 
in a medium containing 8% nutrient broth (Difco) 
and 1.5% NaCl at 37°C and harvested in late log-phase 
(A = 1.0 at 650 nm). The cells were resuspended in 
2 vol. buffer A (10 mM Tris-HCl, pH 7.5, 1 mM 
EDTA, 1 mM 2-mercaptoethanol, 10 mM MgCla, 
10% glycerol) and sonicated four times for 15 s each. 
The extract was centrifuged at 30 000 X g for 60 min 
and the resulting supernatant (S30) was centrifuged 
again at 150 000 X g for 90 min to obtain the SlOO 
extract. The specific activity of pseudouridylate 
synthetase I in the SlOO extract was 30 f 10 units 
of enzyme/mg protein. Pseudouridylate synthetase I
was precipitated from SlOO extract by addition of 
20 mg/ml streptomycin sulphate. The recovery of the 
enzyme activity was about 70% with a specific 
activity of 200 + 50 units/mg protein. It has to be 
emphasized that the optimal concentration of strepto- 
mycin sulphate for the precipitation of the enzyme 
and for the recovery of the activity changed signiti- 
cantly from preparation to preparation and had to be 
determined each time by a pilot experiment. The 
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streptomycin sulphate precipitate was resuspended in 
buffer A, 0.33 M NaCI, at a protein concentration 
of 50 mg/ml, then 450 mg/ml of ammonium sulphate 
were added. After centrifugation the precipitate was 
resuspended in buffer A and desalted on a Sephadex 
G-25 column. After this step there was a recovery of 
about 60% of the enzymatic activity with a specific 
activity of 400-600 units/mg of protein. The 
ammonium sulphate fraction was applied to a DEAE- 
cellulose column (100 mg protein/cm’ resin). The 
flow-rate was half-column bed-volume/hour. After 
washing with two bed volumes of buffer A, a linear 
gradient of NaCl (O-O.185 M) was applied. The 
enzymatic activity eluted at about 50 mM NaCl. The 
fractions containing enzymatic activity were pooled 
and ammonium sulphate was added to reach a 70% 
saturation. After centrifugation the enzyme was 
resuspended in buffer A at a protein concentration 
of 10 mg/ml and stored at 4°C. The specific activity 
of this preparation was about 4000 units/mg of 
protein with a purification factor of 160. 
2.5. Preparation of labeled hisT tRh!A.and CpsO and 
(~80~s~; - RNA 
[ 5-3H] Uridine-labeled hisT tRNA was prepared 
according to Cortese et al. [7]. [5-3H]Uridine-labeled 
$80 RNA and [5-3H]uridine-labeled RNA, [‘“Cl 
uridine-labeled RNA, [(u-~~P] CMP-labeled RNA from 
@8Ops& - phage were prepared by transcribing in 
vitro $80 phage DNA and @Opsus”- phage DNA 
respectively, according to Daniel et al. [11,12]. 
2.6. Pseudouridylate sytithetase assay 
Pseudouridylate synthetase assay was performed as 
described [7] . [5-3H]Uridine-labeled $~OPSU~+‘- RNA 
was found to release tritium in the medium non- 
enzymatically at a rate much higher than [ 5-‘H] 
uridine-labeled hisT tRNA. In order to minimize this 
background radioactivity in our assay, we stored 
@80psu3+‘- RNA in ethanol at -20°C and centrifuged 
and resuspended it every time it was needed. One unit 
of pseudouridylate synthetase is defined as the amount 
of enzyme able to synthesize 1 pmol pseudouridine 
in 10 min at 37°C using [5-3H]uridine-labeled hisT 
tRNA as substrate. 
2.7. Slab-gel electrophoresis 
Electrophoresis on polyacrylamide slab gel was 
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performed on a 30 X 15 X 0.15 cm 16% gel in Tris- 
borate buffer [ 131 at 200 V for 13-l 5 h. 
2.8. Fluorography 
Fluorographic detection of oligonucleotides on 
polyacrylamide gel was performed according to the 
procedure of Bonner and Laskey [ 141. 
2.9. Paper chromatography 
Nucleotides separation was observed by paper 
chromatography. The chromatogram was soaked in a 
7% (w/v) PPO* solution in diethyl ether [ 151. The 
chromatogram was then agitated until the ether had 
evaporated completely and fluorographed on an 
X-ray film (Kodak Regulix BB54). 
3. Results and discussion 
3.1. tRNADr precursor as pseudouridylate synthetase 
substrate 
In vitro transcribed tRNATvr precursor is substrate 
for both pseudouridylate synthetase I and II. The in 
vitro transcription of tRNATvr genes using purified 
RNApolymerase and template [11,12,16,17] has 
provided completely unmodified tRNATYr precursors 
which are suitable substrates for pseudouridylate 
synthetase I, which is lacking in hisT mutants, and 
pseudouridylate synthetase II normally present in 
hisT mutants. 
Using the in vitro transcriptional product of 
q!~8Opsua+‘- DNA as substrate we have assayed the 
pseudouridylate synthetase activities present in the 
strain TA265 (a wild-type S. typhimurium) and in 
the strain TA253 (carrying the hisT 1504 mutation). 
Figure 1 shows that the amount of tritium’ released 
in the medium from [5-‘Hluridine-labeled @8Op~u3+‘- 
RNA, in the presence of TA265 S30 cell-extract, is 
almost twice the amount of tritium released in the 
presence of TA253 S30 cell-extract. This result is in 
agreement with the observation that in vivo TA265 
is able to synthesize both $4o and $a4 [ 181, whereas 
TA253 is able to synthesize only J/W [3]. 
The tritium released in the medium in the presence 
of TA253 S30 cell extract is a measure of the activity 
of pseudouridylate synthetase II, but any attempt to 
* Abbreviation: PPO, 2,SDlphenyloxazole 
I I I I 
I I I 
10 30 
Fig.1. Tritium release as a function of time from [5-3H] 
uridine-labeled in vitro synthesized tRNATyr-precursor in the 
presence of TA265 (o- o) and TA253 (e- 0) S30 cell- 
extract. Enzymatic assay was performed as described [7]. In 
0.1 ml reac;ion mixture [7] 0.2 pg of labeled RNA (1.3 X lo6 
cpm/ng) and 1.2 mg protein were added. 
purify this enzyme failed since every fractionation 
procedure we tried caused the loss of the enzymatic 
activity. On the contrary, pseudouridylate synthetase I
showed to be a less ‘delicate’ enzyme and it could be 
purified about 150 times (see Materials and methods). 
The enzymatic activity was monitored along the whole 
purification procedure by using either [5-3H]uridine- 
labeled hisT tRNA or [5-3H]uridine-labeled #~OPSU~“- 
RNA as substrate: identical results were obtained. The 
last purification step, a DEAE-cellulose column 
chromatography, is shown in Iig.2. The elution profiles 
of pseudouridylate synthetase I, measured using hisT 
tRNA and @~OPSU~+‘- RNA as substrate, are practically 
coincident. 
3.2. Specificity of 3H-release from /5-3Hjuridine- 
labeled tRNA vr precursor 
When the tritium release assay for pseudouridylate 
synthetase I was developed, several evidences were 
provided for its specificity [7]. Here we show that 
tritium is specifically released from [5-3H]uridine- 
labeled in vitro transcribed @~OPSU~“- RNA incubated 
in the presence of partially purified pseudouridylate 
synthetase I. As shown in fig.3, upon incubation with 
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Fig.2. DEAE-Cellulose column chromatography of pseudo- 
uridylate synthetase I. The sample deriving from ammonium 
sulphate fractionation, containing 380 mg protein was 
applied to a 1.5 X 7 cm column. The column was developed 
with 200 ml of a linear NaCl-gradient (O-0.185 M) in buffer 
A, at a flow-rate of 5 ml/h and 1.5 ml fractions were 
collected. Enzymatic assay was performed on 30 nl aliquots 
of each fraction as described in the legend to fig.1 and in 
ref. [ 71. The incubation time was 20 min; (+- +) absor- 
bance at 280 nm; (o -0) activity measured with [5-3H] 
uridine-labeled tRNATyr precursor; (e -0) activity 
measured with [5-3H]uridine-labeled hisT tRNA. 
the enzyme, [ 5-3H]uridine-labeled $~OPSU~+‘- RNA 
releases 15 times more tritium in the medium 
(Curve 1) than [5-3H]uridine-labeled $80 RNA, 
which does not contain tRNATvr sequences 
(Curve 2) It is interesting to note that, in this 
experiment, $80 RNA releases an amount of tritium 
in the medium which is about twice higher than the 
background of non-enzymatic release. Although no 
pseudouridine has been found until now in messenger 















Fig.3. Tritium release as a function of time from [5-3H] 
uridine-labeled @~O~SU,+~- (o -0) and $80 (.---.) 
RNA. Assay conditions were as described in the legend to 
Bg.1. Partially purified pseudouridylate synthetase I was 
7 ng/O.l ml assay mixture. Labeled @8Opsua+~- and 080 
RNA had the same specific activity (2.7 X lo6 cpm/pg) and 
were added in the same amount (0.2 pg10.1 ml incubation 
mixture). 
scribed’ RNA contains sites which can be recognized 
by pseudouridylate synthetase enzyme. 
Further evidence for the specificity of the tritium 
release reaction has been provided from an experiment 
in which we measured the inhibition exerted by cold 
tRNA on the tritium release from [5-3H] uridine- 
labeled #~OPSU~+‘- RNA during incubation in the 
presence of partially purified pseudouridylate 
synthetase I (fig.4). A marked inhibition by cold wild- 
type tRNA was observed (Curve a). This inhibition is 
also observed when [5-3H]uridine-labeled hisT tRNA 
is used as substrate (Arena, F., Ciampi, M. S., 
Ciliberto, G. and Cortese, R., manuscript in prepara- 
tion) and it is probably a general property of the 
enzyme. The inhibition exerted by cold hisT tRNA 
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Fig.4. Effect of cold wild-type tRNA (o- o) and cold hisT 
tRNA (.-- l ) on tritium release from [S-‘H] uridine-labeled 
tRNATyr precursor incubated with partially purified pseudo- 
uridylate synthetase I. Assay conditions were as described in 
the legend to fig.3. The incubation time was 10 min. 
was however more severe and complete (Curve b) as 
one would expect if tRNATyr precursor and hisT 
tRNA had to compete for the same site on the enzyme 
molecule. 
The mechanism of pseudouridine synthesis is not 
known in detail and it is possible that it occurs by a 
multistep process involving, at a certain stage, the 
release of tritium from carbon 5 of the pyrimidine 
ring. Therefore, when the amount of tritium released 
in the medium is measured, it might be that only a 
partial reaction is measured, without any information 
on whether it goes to completion and pseudouridine 
residues are synthesized. With respect to this point it 
was shown that, using [ 5-3H]uridine-labeled hisT 
tRNA and [32P]hisT tRNA as substrate and wild-type 
SlOO cell-extract, the tritium release was paralleled 
by synthesis of pseudouridine identified in the [32P] 
tRNA hydrolysate by its characteristic electrophoretic 
and chromatographic behaviour [7]. Figure 5 shows 
that this is true also using partially purified pseudo- 
uridylate synthetase I instead of crude extract and 
[cu-~‘P] CMP-labeled tRNATYr precursor instead of 
hisT tRNA as substrate. 
Fig.5 Paper chromatography of alkaline hydrolysate of in 
vitro pseudouridylated [w~~P]CMP-labeled tRNATyr 
precursor. [32P]CMP RNA 1.4 I.rg (1.5 X 10’ cpm/Mgg) were 
incubated with 50 c(g of partially purified pseudouridylate 
synthetase I for 15 min as described in the legend to fig.1. 
The reaction was stopped by adding 4 pg of cold carrier 
S. typhimurium tRNA and 100 ~1 of 0.1 M Tris-HCl saturated 
phenol pH 7.5. The RNA was extracted, alkali digested and 
the resulting nucleotides were fractionated by high-voltage 
electrophoresis on Whatman No. 52 paper in pyridine acetate 
buffer pH 3.5 [ 191. The spot corresponding to UMP was 
eluted, UMP and $JMP were separated by paper chromato- 
graphy in isopropanol-HCl-water (680 : 176 : 144, v/v/v) 
system [ 191 and evidenced by autoradiography. 
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Fig.6. Left panel: fluorogram of 16% polyacrylamide gel electrophoretic separation of Tl digested [ i4C]uridine-labeled tRNATyr 
precursor. Labeled RNA precursor, 1 pg, was incubated with 70 pg pseudouridylate synthetase I for 20 min as described in the 
legend to fig.1. The reaction was stopped by addition of 10 pg of cold tRNA and 100 ~1 Tris-saturated phenol. RNA was 
extracted, digested by Tl RNAase [ 191 and the oligonucleotide fragments were fractionated by electrophoresis on 16% poly- 
acrylamide gel [ 131. As markers in parallel slots [ 5-sH] uridine labeled 4 S RNA from 5’. typhimurium and T$CG tetranucleotide, 
purified from a Tl digest of [ methyZ-3H] methionine-labeled tRNA of S. typhimurium, were run. After fluorography oligo- 
nucleotides were extracted from Regions 1 and 2 of the gel by a procedure which will be published elsewhere (Bossi, L. and 
Ciampi, M. S., manuscript in preparation) and digested by alkali. UMP and $MP were separated by paper chromatography as 
described in the legend to fig.5 and evidenced by fluorography. The film was scanned by a Gilford spectrophotometer Mod 2400 
at 550 nm. On the right panel are the film densitometric scanning profiles of $MP and UMP contained in oligonucleotides 
extracted from Region 1 (Profile 1) and 2 (Profile 2) of the gel. 
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3.3. $40 Synthesis at the uncleaved tRNADr-precursor 
level 
The two pseudouridine modifications contained in 
both tRNATYr su; and tRNATYT su3- sequences can 
be easily distinguished. After Tl RNAase digestion in 
tRNATYr su; J140 is contained in a dodecanucleotide 
fragment and in tRNATYr su3- it is contained in an 
octanucleotide, whereas $64 is contained only in the 
tetranucleotide T$CG in both cases. Our partially 
purified pseudouridylate synthetase I is able to 
synthesize only $40 and not $64. After incubation 
with the enzyme preparation [ 14C] uridine-labeled 
48Opsu;‘- RNA was hydrolyzed with Tl RNAase 
and the resulting fragments were separated by electro- 
phoresis on 16% polyacrylamide gel (fig.6, left panel). 
Oligonucleotides were extracted from two regions of 
the gel: Region 2 at the level of a tetranucleotide 
marker, run in a parallel slot of the gel, and Region 1 
which, on the basis of the relationship between 
molecular weight and migration distance on poly- 
acrylamide gel electrophoresis [20], should contain 
both the dodecanucleotide and the octanucleotide 
fragments. The oligonucleotides were subjected to 
alkaline hydrolysis and the resulting nucleotides 
were separated by paper chromatography. In fig.6 
(right panel) scanning Profile 1 shows that a consider- 
able amount of pseudouridine is found in the oligo- 
nucleotides extracted from gel Region 1 and scanning 
Profile 2 shows that only uridine is present in the 
tetranucleotides extracted from gel Region 2. 
Since our partially purified pseudouridylate 
synthetase I is free of nucleases (the size of the in 
vitro transcribed tRNATYr precursor, which migrates 
as an 85 RNA molecule on acrylamide gel electro- 
phoresis [ 1 l] , does not change after incubation with 
the enzyme, data not shown), the results described 
above constitute a good evidence that $4,~ can be 
synthesized at the level of uncleaved tRNATYr sus+, 
su3- precursor. This is in agreement with the results 
reported by Guthrie et al. [8] and Sakano et al. [9], 
but not with those of Shaefer et al. [lo] who found 
that $40 could be synthesized in vitro only after 
cleavage of tRNATYr sus+ A25 precursor by RNAase 
P. A possible explanation for this discrepancy is that 
Shaefer et al. used a tRNATYr-precursor, extracted 
from E. coli cells infected with 80psu3+ A25 mutant 
phage, which reaches an abnormally high intracellular 
concentration because of its reduced sensitivity in vivo 
to RNAase P. It is therefore conceivable that this RNA 
precursor is altered in such a way as to be generally a 
bad substrate for many maturation enzymes, including 
pseudouridylate synthetase I. It is relevant to this point 
the finding that a single point mutation in tRNA 
genes can lead to trqnscriptional products which are 
not recognized by the majority of modifying 
enzymes [21]. 
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